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1  | INTRODUC TION
Migraine is a common primary, although clearly not exclusively, 
headache disorder characterized by recurrent episodes of headache 
often associated with nausea, vomiting, photophobia, and phono-
phobia. The manifestations of migraine clinically can be protean 
and may not include headache or only mild headache (although this 
is a primary requirement for the diagnosis in many classifications; 
Headache Classification Committee of the International Headache 
Society (IHS), 2013). It is a major cause of disability and is among 
the top 10 causes of years lived with disability in the world (Global 
Burden of Disease Study 2013 Collaborators, 2015).
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Abstract
Objectives: Population prevalence studies of migraine report prevalence rates of be-
tween 2.6 and 21.7%, with an average of ~12%. However, migraine prevalence among 
neurologists is reported to be significantly higher, between 27.6% and 48.6%. 
Increasing knowledge of the protean manifestations of migraine may explain this dif-
ference. Similarly, under- recognition of migraine in control groups may explain the 
lack of genetic and biomarker findings in this disorder. We therefore sought to deter-
mine the prevalence of migraine in an admixed group of individuals with varied 
knowledge of migraine symptomatology.
Methods:	Attendees	at	the	Australian	and	New	Zealand	Association	of	Neurologists	
Annual	Scientific	Meeting	(ANZAN	ASM)	2017	were	surveyed	anonymously.	Those	
surveyed included three groups: neurologists, neurology trainees, and others includ-
ing nonclinical researchers, members of lay organizations, and representatives of the 
pharmaceutical industry.
Results: In total, 313 of 606 attendees responded (51.7%). 65.9% of neurologist, 
57.4% of trainee, and 52.5% of others respondents had a personal history of mi-
graine, with the difference between neurologists and others being statistically sig-
nificant (p = .03). Migraine in migraineurs and nonmigraine headache in nonmigraineurs 
were	nearly	all	self-	diagnosed.	Among	neurologist	migraineurs,	51.2%	experienced	
migraine with aura and 43% migraine without aura.
Conclusions: Migraine prevalence is significantly higher in neurologists compared to 
non- neurologists and at least 2–3 times higher than reported in population preva-
lence studies. This may be due to significant under- recognition of migraine in non- 
neurologists. This under- recognition of migraine may significantly influence the 
search for genetic predictors and biomarkers of migraine.
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Migraine prevalence is reported as between 2.6% and 21.7%, 
with an average of ~12%, with variation between countries and also 
between	 studies	within	 the	 same	 country	 (Burch,	 Loder,	 Loder,	&	
Smitherman,	 2015;	 Lipton,	 Stewart,	 Diamond,	 Diamond,	 &	 Reed,	
2001; Merikangas, 2013; Wang, 2003). There is a strong familial link 
in migraineurs suggesting a large genetic component to migraine risk 
(Dzoljic	et	al.,	2014;	Hernandez-	Latorre	&	Roig,	2000;	Merikangas,	
2013;	 Russell	 &	Olesen,	 1995;	 Stewart,	 Staffa,	 Lipton,	 &	Ottman,	
1997). Twin studies have shown that migraine is a complex genetic 
disease with interplay between genetic and environmental factors, 
with heritability estimated to be as high as 65% (Gervil, Ulrich, Kaprio, 
Olesen,	&	Russell,	1999;	Honkasalo	et	al.,	1995;	Mulder	et	al.,	2003;	
Svensson,	 Larsson,	Waldenlind,	 &	 Pedersen,	 2003;	 Ulrich,	 Gervil,	
Kyvik,	Olesen,	&	Russell,	1999).
Surprisingly, despite several large genomewide association stud-
ies	 (GWAS)	being	undertaken	 (Anttila	 et	al.,	 2010;	Chasman	et	al.,	
2011;	 Freilinger	 et	al.,	 2012),	 no	 conclusive	 candidate	 genes	 have	
been identified, with a recent systematic re- evaluation of 27 can-
didate genes identifying none as being statistically significant (De 
Vries et al., 2016).
Migraine prevalence in neurologists is higher compared to the 
general population with prevalence of up to 48.6% seen among 
neurologists	 (Alstadhaug,	 Hernandez,	 Naess,	 &	 Stovner,	 2012;	
Donnet,	Becker,	Allaf,	&	Lantéri-	Minet,	2010;	Evans	&	Evans,	2010;	
Evans	&	Ghosh,	2016;	Evans,	Lipton,	&	Ritz,	2007;	Evans,	Lipton,	&	
Silberstein,	2003;	Gil-	Gouveia,	2014;	Lu,	Wang,	&	Fuh,	2006).	The	
reason for this is almost certainly better self- recognition of symp-
toms corresponding to migraine by those trained and experienced in 
the manifestations of migraine. This was shown in a study in which 
only just over half of individuals identified as having a diagnosis of 
migraine	recognized	that	their	headache	was	in	fact	migraine	(Lipton,	
Stewart,	&	Liberman,	2002).
In this study, we aim to examine migraine prevalence among 
neurologists, neurology trainees, and non- neurologists/trainees at 
a national neurology meeting. We hypothesize that the neurologists 
will have the highest prevalence, followed by trainees and then non- 
neurologists/trainees, and that the prevalence of migraine among 
neurologists will be significantly higher than the reported population 
level prevalence of migraine.
If our hypothesis is correct, this may explain the lack of genetic 
associations and biomarkers found due to under- recognition within 
population studies and therefore inclusion of significant numbers of 
false negatives in the control groups. If as hypothesized recognition 
is the problem, then careful phenotyping of the control and affected 
study groups is the only alternative in the absence of a biomarker of 
disease.
2  | METHODS
2.1 | Subjects
Attendees	 at	 the	 Australian	 and	 New	 Zealand	 Association	 of	
Neurologists	Annual	 Scientific	Meeting	 (ANZAN	ASM)	2017	were	
surveyed	anonymously.	Attendees	were	considered	in	three	groups:	
(1) neurologists, (2) neurology trainees, and (3) others, with this 
group consisting predominantly of representatives of pharmaceu-
tical, scientific and lay support organizations and nonclinical re-
search personnel. Ethical approval was obtained from the Southern 
Tasmanian human research ethics committee.
2.2 | Survey
A	single-	page	survey	was	designed	with	questions	divided	into	three	
main sections. The first section asked demographical information 
including gender, age, and group. The second section enquired re-
garding family history of migraine, personal history of migraine or 
headache, and who made the diagnosis of the headache phenotype. 
The third section was directed at neurologists and asked whether 
they considered themselves a headache specialist, whether their his-
tory of migraine influenced their career decision, and what migraine 
types	were	experienced.	A	description	of	study	objectives	and	the	
International Classification of Headache Disorders (ICHD) third edi-
tion criteria for migraine were provided.
2.3 | Statistical analysis
The mean and standard deviation (SD) of each continuous variable, 
and the percentage and frequency of the attributes of each categori-
cal variable, are reported to summarize the characteristics of each 
group of participants. Tests of the statistical significance of differ-
ences between groups were undertaken using analysis of variance 
methods (continuous variables) and chi- square tests of independ-
ence (categorical variables). Prevalence and ratios of prevalence 
were estimated using generalized linear models with a binomial error 
distribution and logarithmic link (log binomial regression). By adding 
covariates for age and sex to the model, the estimated prevalence 
and	prevalence	ratios	were	adjusted	for	those	factors.	A	two-	sided	
p value < .05 was considered statistically significant. Statistical 
analyses were performed in Microsoft Excel and using Stata (Stata 
Corporation).
3  | RESULTS
Of	606	 total	 attendees	at	ANZAN	ASM	2017,	313	completed	 the	
survey for an overall response rate of 51.7%. One respondent did 
not answer which group they belonged to and was excluded from 
analysis. Respondent demographics and proportions with family and 
personal history of migraine are given in Table 1. The overall regis-
tration	figure	included	254	ANZAN	members	(neurologists/trainees)	
giving a response rate of 76% for these two groups (we cannot sub-
divide further due to lack of data).
In terms of personal history of migraine, neurologists had the 
highest proportion (65.9%), followed by neurology trainees (57.4%), 
and others (52.5%). The difference between neurologists and oth-
ers was statistically significant (proportion difference 13.4%, 95% 
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confidence interval (CI) 1.51%–25.4%, p = .03) but the differences 
between neurologists and trainees, and trainees and others, were 
not (p = .27 and 0.55, respectively).
A	 family	 history	 of	migraine	was	 highest	 again	 in	 neurologists	
(55.1%). The differences between neurologists and trainees (propor-
tion difference 21.7%, 95% CI 6.67%–36.8%, p = .007), and neurolo-
gists and others (proportion difference 14.2%, 95% CI 2.15%–26.3%, 
p = .02) were significant, but not between trainees and others 
(p = .35).
Examining prevalence by sex, neurologists had a higher preva-
lence of migraine compared to others with this being significant for 
males (p = .003) but not for females (p = .37; Table 2). Within groups, 
there was no significant difference between males and females ex-
cept for migraine prevalence in others (p = .002).
After	adjustment	for	age	and	sex,	the	prevalence	of	a	personal	
history of migraine among trainees was statistically indistinguish-
able from prevalence among the neurologists (prevalence ratio 
PR = 0.91, p = .56), but prevalence among others was significantly 
lower (PR = 0.80, p = .03) than the prevalence among neurolo-
gists. In this model, age (PR = 1.01 per year, p = .04) and female sex 
(PR = 1.19, p = .05) were significant predictors of the prevalence of a 
personal history of migraine.
3.1 | Diagnosis of migraine and headache
In those with a personal history of migraine, the majority self- 
diagnosed their migraine (85.7% in the neurologist group, 90.3% 
in the trainee group, and 44.4% in the others group). 33.3% of mi-
graineurs in the others group were diagnosed by a non- neurologist 
physician, followed by 15.9% by neurologists.
Of the nonmigraineurs, 36.2% in the neurologist group, 60.9% in 
the trainee group, and 40.4% in the others group described having pre-
vious	headaches.	All	of	the	respondents	in	the	neurologist	and	trainee	
groups had self- diagnosed their headaches as not migraine, compared 
to 91.3% in the others group. The remaining 8.7% in the others group 
were diagnosed by non- neurologist physicians.
Neurologists 
(N = 138)
Neurology trainees 
(N = 54)
Others 
(N = 120) All (N = 312)
Gender
Female	(%) 50 (36.2) 24 (44.4) 70 (58.3) 144 (46.2)
Male (%) 88 (63.8) 30 (55.6) 50 (41.7) 168 (53.8)
Age—years
Mean (SD) 49.4 (11.7) 32.3 (4.1) 43 (10.1) 44 (11.8)
Range 30–82 27–45 22–75 22–82
Migraine
Family	history	
(%)
76 (55.1) 18 (33.3) 49 (40.8) 143 (45.8)
Personal 
history (%)
91 (65.9) 31 (57.4) 63 (52.5) 185 (59.3)
TABLE  1 Respondent characteristics
Neurologists 
(N = 138)
Trainees 
(N = 54)
Others 
(N = 120) All (N = 312) p- Valuesa
Female—n 50 24 70 144
Personal history 
(%)
36 (72) 11 (45.8) 45 (64.3) 92 (63.9) .03 
.37 
.11 
Family	history	
(%)
28 (56) 9 (37.5) 31 (44.3) 68 (47.2) .14 
.21 
.56 
Male—n 88 30 50 168
Personal history 
(%)
55 (62.5) 20 (66.7) 18 (36) 93 (55.4) .68 
.003 
.008
Family	history	
(%)
48 (54.5) 9 (30) 18 (36) 75 (44.6) .02 
.04 
.58 
ap- Values comparing neurologists to trainees, neurologists to others, and trainees to others, 
respectively.
TABLE  2 Personal history and family 
history of migraine by sex
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Thirteen female neurologists and 15 male neurologists described 
themselves	as	headache	specialists.	Female	nonheadache	specialists	
had the highest proportion with a personal history of migraine, fol-
lowed by female headache specialists, male nonheadache special-
ists, and male headache specialists (73% vs. 69.2% vs. 64.4% vs. 
53.3%, P = NS).
Of the neurologists with a personal history of migraine, two 
(2.2%) responded that this influenced their career decision to be-
come a neurologist. 86 provided responses regarding their migraine 
type	 (Figure	1),	with	 the	most	 common	 types	being	migraine	with	
aura (51.2%) and migraine without aura (43.0%). Thirteen responded 
that they had experienced two migraine types. In terms of aura sub-
type in respondents with migraine with aura and probable migraine 
with aura, the most common was typical aura (86.7%) followed by 
retinal migraine (8.9%) and brainstem aura (4.4%). No other aura sub-
types were selected.
4  | DISCUSSION
To our knowledge, this is the first study examining migraine preva-
lence in neurologists to also include non- neurologist and nonphy-
sician groups for comparison. Our overall response rate of 51.7% 
was comparable to other survey- based studies of migraine in neu-
rologists, although our response rate from neurologists and train-
ees of 76% is higher compared to most of these previous studies 
(Alstadhaug	et	al.,	2012;	Donnet	et	al.,	2010;	Evans	&	Evans,	2010;	
Evans	&	Ghosh,	2016;	Evans	et	al.,	2003,	2007;	Gil-	Gouveia,	2014;	
Lu	et	al.,	2006).	As	 in	previous	studies,	we	demonstrated	a	signifi-
cantly higher prevalence of migraine in neurologists (65.9%) than 
would be expected based on population prevalence studies. Groups 
demonstrated increasing prevalence with neurological experience, 
with the highest prevalence in neurologists and lowest prevalence 
in others. The proportion with a positive family history of migraine 
was also higher in neurologists compared to others. Better recogni-
tion and increased awareness of migraine and its features among 
neurologists are highly likely to explain these differences.
Stratifying by sex also demonstrated higher prevalence of mi-
graine and family history of migraine in neurologists compared to 
non- neurologists/trainees. The differences were more marked in 
males than females. This may be due to lower awareness of migraine 
in males compared to females, and thus, population prevalence of 
migraine in males may be underestimated.
Nearly all of the diagnoses of migraine in migraineurs and non-
migraine headache in nonmigraineurs were made by the respondent. 
Among	 nonmigraineurs	 with	 headache	 in	 the	 others	 group,	 none	
were diagnosed by a neurologist. This highlights the significant risk 
of under- recognition and undertreatment of migraine in this group 
and by inference the general population.
Apart	from	increased	recognition,	another	explanation	for	higher	
migraine prevalence in neurologists is that their history of migraine 
predisposes them to pursue a career in neurology. This hypothesis 
was not supported by our findings, with only 2 of 91 neurologists 
with a history of migraine responding that their migraine history in-
fluenced their career decision.
The most common type of migraine experienced by the neurol-
ogist group was migraine with aura. This is again different to pop-
ulation studies where migraine without aura is more common than 
migraine with aura. Our finding may again be due to better recog-
nition of aura by neurologists compared to the general population, 
with this also supported by findings from a study of Norwegian neu-
rologists	(Alstadhaug	et	al.,	2012).	The	presence	of	aura	was	based	
on neurologists’ self- assessment, and another possible reason for 
our finding is varied definitions of what constitutes aura among neu-
rologists as compared to strict definition as per ICHD criteria.
The proportion with a personal history of migraine in the others 
group is higher than might be expected in the general population. 
This group mostly consisted of representatives from pharmaceu-
tical and scientific companies, and thus, they were likely to have 
greater education levels regarding neurological diseases relative to 
the population average, with increased knowledge and therefore 
better recognition of migraine. There is, however, also likely signifi-
cant selection bias particularly of the others group with migraineurs 
more likely to participate in our study. There may also be significant 
differences in terms of demographics between responders and 
nonresponders. It could be expected that if a larger proportion of 
non- neurologists/trainees were captured, the difference in migraine 
prevalence between neurologists and others may be larger than 
demonstrated in our study. The lower number of respondents in the 
F IGURE  1 Neurologists with a personal history of migraine 
and	their	migraine	types.	Labels	formatted	as	group,	frequency,	
proportion as percent. Migraine with aura, migraine without aura, 
and probable migraine with aura values, and percentages refer to 
respondents who listed these alone
Migraine with aura, 
34, 39.5%
Migraine without aura, 
24, 27.9%
Probable migraine 
without aura, 9, 10.5%
Probable 
migraine with 
aura, 6, 7.0%
Migraine without 
aura + migraine 
with aura, 10, 
11.6%
Migraine without aura 
+ probable migraine 
with aura, 2, 2.3%
Migraine without aura 
+ menstrual migraine, 
1, 1.2%
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neurology trainee group reflects lower overall numbers in this group, 
given	there	are	only	130	trainees	in	Australia	and	New	Zealand.	On	
adjustment for age and sex, this group was statistically similar to the 
neurologist group.
Our estimated overall response rate was 51.7% which may intro-
duce response bias, with those with a personal history of migraine 
potentially more likely to respond to a migraine prevalence study. 
The response rate in neurologists/trainees was 76% which minimizes 
response bias of these groups. However, even assuming the maxi-
mum denominator possible for the neurologist and trainee groups, 
the migraine prevalence would still be significantly higher (twofold 
to threefold) than expected based on population prevalence stud-
ies. It is highly likely that the responses from the neurologist/trainee 
groups captured the whole spectrum of migraine with several re-
spondents noting that they had only ever had a handful of migraines 
in their lives and with several also noting that they had only ever 
had migraine auras. Our study relied on self- reporting of migraine 
with the assumption that neurologists and trainees were familiar 
with ICHD criteria for migraine and its subtypes, although a copy 
of these criteria was provided to participants. However, it cannot 
be excluded that some participants, particularly others, were not 
familiar with these criteria and thus there may be both under- and 
over- recognition of migraine.
Our findings show a significantly higher prevalence of migraine 
in neurologists compared to non- neurologists. However, given the 
limitations of our study, conclusions should be drawn with cau-
tion. The most likely explanation is under- recognition of migraine 
among non- neurologists and increased awareness of migraine 
and its manifestations by neurologists. Thus, the true population 
prevalence of migraine may be significantly higher than previously 
determined and may explain the difficulties in finding genes for 
migraine.	Many	clinic-	and	population-	based	migraine	GWAS	have	
unscreened population- matched controls inferring that these con-
trol groups are expected to have similar migraine prevalence to 
the	general	population	(Anttila	et	al.,	2010;	De	Vries	et	al.,	2016).	
Questionnaires are often used to select for cases and controls in 
population-	based	GWAS	 thus	 introducing	 the	 possibility	 of	mis-
recognition of nonmigraineur status among controls. Careful se-
lection and phenotyping of control and case groups in migraine 
genetic, biomarker, and other studies may be the only methodol-
ogy to allow for true differences to be identified.
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